Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Science & Technology Watch.
Press releases published on July 23, 2025
Solid Biosciences Receives FDA Fast Track Designation for SGT-501 First-in-Class Gene Therapy for Catecholaminergic Polymorphic Ventricular Tachycardia (CPVT)
GlobeNewswire
·
July 23, 2025
- SGT-501 has now received FDA Fast Track, Orphan Drug and Rare Pediatric Disease designations - - Potential first-in-class therapy with FDA IND clearance and Health Canada CTA approval designed to address underlying causes of CPVT, a life-threatening, …
Aventis Energy Announces Results of High-Resolution TDEM Survey at the Corvo Uranium Project in Northern Saskatchewan
GlobeNewswire
·
July 23, 2025
VANCOUVER, British Columbia, July 23, 2025 (GLOBE NEWSWIRE) -- Aventis Energy (“Aventis” or the “Company”) (CSE: AVE | FRA: C0O0 | OTC: VBAMF) is pleased to provide a summary of results from an airborne Time Domain Electromagnetic (“TDEM”) survey (the “ …
Ambulatory Surgery Center Completes WATER IV Trial Procedures for Prostate Cancer with Aquablation® Therapy
GlobeNewswire
·
July 23, 2025
SAN JOSE, Calif., July 23, 2025 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics® Corporation (Nasdaq: PRCT) (the “Company”), a surgical robotics company dedicated to advancing patient care through transformative urology solutions, today announced that three …
Opus Genetics and the Global RDH12 Alliance Partner to Advance RDH12 Gene Therapy for Inherited Childhood Blindness
GlobeNewswire
·
July 23, 2025
Collaboration aims to accelerate development of OPGx-RDH12, a gene therapy for RDH12-associated Leber congenital amaurosis (RDH12-LCA) RESEARCH TRIANGLE PARK, N.C., July 23, 2025 (GLOBE NEWSWIRE) -- Opus Genetics, Inc. (Nasdaq: IRD), a clinical-stage …
Lexicon Pharmaceuticals to Report Second Quarter 2025 Financial Results on August 6, 2025
GlobeNewswire
·
July 23, 2025
THE WOODLANDS, Texas, July 23, 2025 (GLOBE NEWSWIRE) -- Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX) today announced the Company will release its second quarter 2025 financial results on Wednesday, August 6, 2025, prior to market open. Management will …
Jupiter Neurosciences Highlights Critical Advancement of JOTROL™ Over Traditional Resveratrol with Breakthrough Bioavailability and CNS-Targeted Science
GlobeNewswire
·
July 23, 2025
Transforming a promising molecule into a clinically viable therapeutic platform Jupiter, Florida, July 23, 2025 (GLOBE NEWSWIRE) -- Jupiter Neurosciences, Inc. (NASDAQ: JUNS) ("Jupiter" or the "Company"), a clinical-stage pharmaceutical company developing …
red violet to Announce Second Quarter 2025 Financial Results on August 6, 2025
GlobeNewswire
·
July 23, 2025
BOCA RATON, Fla., July 23, 2025 (GLOBE NEWSWIRE) -- Red Violet, Inc. (NASDAQ: RDVT), a leading analytics and information solutions provider, announced today that it will report its financial results for the second quarter ended June 30, 2025 after the …
Cycurion Shines as Diamond Affiliate Partner at NACCHO Annual Conference, Showcasing High-Margin Cyber Shield Solution to Address Public Health Cybersecurity Challenges
GlobeNewswire
·
July 23, 2025
MCLEAN, Va., July 23, 2025 (GLOBE NEWSWIRE) -- Cycurion, Inc. (Nasdaq: CYCU) (“Cycurion”), a leader in innovative, high-margin cybersecurity solutions, attended the National Association of County and City Health Officials (NACCHO) Annual Conference ( …
BigCommerce, Brave Bison, The Journey and Pimberly Launch ‘Branch of the Future’ Accelerator to Digitally Transform the UK Building Material Supplies Sector
GlobeNewswire
·
July 23, 2025
AUSTIN, Texas, July 23, 2025 (GLOBE NEWSWIRE) -- BigCommerce (Nasdaq: BIGC), a leading open SaaS ecommerce platform for B2B and B2C businesses, today announced the launch of a powerful ecommerce accelerator purpose-built for the UK building materials …
Humacyte Announces First Symvess™ Sale to Military Treatment Facility
GlobeNewswire
·
July 23, 2025
Sale follows recent Electronic Catalog (ECAT) listing approval by U.S. Defense Logistics Agency Symvess now available to U.S. Department of Defense and U.S. Department of Veterans Affairs facilities DURHAM, N.C., July 23, 2025 (GLOBE NEWSWIRE) -- Humacyte, …
NevGold Announces Up to 92% Antimony Recovery From Positive Metallurgical Testwork Program at Oxide Gold-Antimony Limo Butte Project in Nevada
GlobeNewswire
·
July 23, 2025
Vancouver, British Columbia, July 23, 2025 (GLOBE NEWSWIRE) -- NevGold Corp. (“NevGold” or the “Company”) (TSXV:NAU) (OTCQX:NAUFF) (Frankfurt:5E50) is pleased to announce extremely positive antimony (“Antimony”, “Sb”) metallurgical testwork results at its …
Byrna Technologies Reports Strong Direct-to-Consumer Prime Day and July 4th Sales, Growth in Brick & Mortar Presence Underscores Omnichannel Growth Momentum
GlobeNewswire
·
July 23, 2025
ANDOVER, Mass., July 23, 2025 (GLOBE NEWSWIRE) -- Byrna Technologies Inc. (“Byrna” or the “Company”) (Nasdaq: BYRN), a personal defense technology company specializing in the development, manufacture, and sale of innovative less-lethal personal security …
Respiree Closes US$11.6M Series A Financing Round Led by We Venture Capital and ClavystBio
GlobeNewswire
·
July 23, 2025
HOUSTON and SINGAPORE, July 23, 2025 (GLOBE NEWSWIRE) -- Respiree, a health tech company developing artificial intelligence (AI) platforms to manage disease progression across the healthcare continuum, announced the successful closing of a US$11.6 million …
Quanta Announces Leadership Team Appointment and Highlights Clinical Program Progress
GlobeNewswire
·
July 23, 2025
– 25-year industry veteran Vanessa L. Jacoby appointed CBO and CFO, bringing financial and strategic leadership – – Enrollment initiated in dose expansion cohorts in Phase 1 clinical trial of QTX3034, an oral G12D-preferring multi-KRAS inhibitor, in …
Ascentage Pharma to Participate in BTIG Virtual Biotechnology Conference 2025
GlobeNewswire
·
July 23, 2025
ROCKVILLE, Md. and SUZHOU, China, July 23, 2025 (GLOBE NEWSWIRE) -- Ascentage Pharma Group International (NASDAQ: AAPG; HKEX: 6855) (“Ascentage Pharma” or the “Company”), a global biopharmaceutical company dedicated to addressing unmet medical needs in …
Belite Bio to Participate in the BTIG Virtual Biotechnology Conference
GlobeNewswire
·
July 23, 2025
SAN DIEGO, July 23, 2025 (GLOBE NEWSWIRE) -- Belite Bio, Inc (NASDAQ: BLTE), a clinical-stage drug development company focused on advancing novel therapeutics targeting degenerative retinal diseases that have significant unmet medical needs, today …
Revolution Medicines Announces FDA Breakthrough Therapy Designation for Elironrasib
GlobeNewswire
·
July 23, 2025
Breakthrough Therapy Designation granted to elironrasib for the treatment of adult patients with KRAS G12C-mutated locally advanced or metastatic non-small cell lung cancer who have received prior chemotherapy and immunotherapy but have not been previously …
Alzamend Neuro Reports Annual 2025 Financial Results and Provides Update on Clinical Programs
GlobeNewswire
·
July 23, 2025
During the year ended April 30, 2025, net cash provided by financing activities was $10.4 million Stockholder equity of $4.0 million at April 30, 2025, including $3.9 million of cash In May 2025, Alzamend dosed the first patient for the healthy human …
NANO Nuclear Completes Assembly of its Proprietary Annular Linear Induction Pump Technology Prototype for Critical Test Loop Validation in SBIR Phase III Program
GlobeNewswire
·
July 23, 2025
Milestone demonstrates NANO Nuclear’s ability to bring advanced nuclear technology from initial design to construction and demonstration New York, N.Y., July 23, 2025 (GLOBE NEWSWIRE) -- NANO Nuclear Energy Inc. (NASDAQ: NNE) (“NANO Nuclear” or “the …
Regen BioPharma, Inc. to Seek Orphan Drug Designation for Lead Product
GlobeNewswire
·
July 23, 2025
An Orphan Drug Designation Could Provide Significant Benefits to Regen SAN DIEGO, July 23, 2025 (GLOBE NEWSWIRE) -- Regen BioPharma, Inc. (OTC Pink: RGBP and RGBPP) today provides further insight into its planned Phase 1 clinical trial of HemaXellerate, …